Today's Top Stories


Hot Topics


Comment & Analysis »

Elly Earls

Ibuprofen: could this ubiquitous drug be entering a whole new era?

Ibuprofen could soon be entering a new era, thanks to breakthrough research on the cardiovascular effects of one formulation of the drug. With one eye on the future, we look back at...

Ibuprofen: could this ubiquitous drug be entering a whole new era?
Aninda Chakraborty

November's top stories: Patheon to buy API facility, UK NICE approved Celgene’s drug

November's top stories: Patheon to buy API facility, UK NICE approved Celgene’s drug
GlobalData Healthcare

Keytruda data fuels debate over PD-L1 as a biomarker in metastatic bladder cancer

Keytruda data fuels debate over PD-L1 as a biomarker in metastatic bladder cancer

Pfizer’s big antibiotic buyout: a sign of things to come?

Pfizer’s big antibiotic buyout: a sign of things to come?
 

Ketamine: taking aim at depression

Ketamine: taking aim at depression

Company Releases »

Control of Humidity at Europe’s First -80°C Cold Store

Munters Control of Humidity at Europe’s First -80°C Cold Store

Setting the Standard for Drug Delivery

Aptar Pharma
Setting the Standard for Drug Delivery

High-Quality Air Treatment Solutions for Pharma Production

Munters High-Quality Air Treatment Solutions for Pharma Production

Pharmaceutical Insights »

Pharmaceutical Industry Reports »

Report: Global neurodegenerative disorders market to reach $45bn by 2022

Report: Global neurodegenerative disorders market to reach $45bn by 2022

Report: Israeli pharmaceutical market to grow at compound annual growth rate of 3.9%

Report: Israeli pharmaceutical market to grow at compound annual growth rate of 3.9%

Report: Non-small-cell lung cancer market to reach $20bn by 2025

Report: Non-small-cell lung cancer market to reach $20bn by 2025

Report: Myelofibrosis market to grow at the compound annual growth rate of 6.4% by 2025

Report: Myelofibrosis market to grow at the compound annual growth rate of 6.4% by 2025